Hydroxyzine requires a prescription because it crosses into the brain far more readily than over-the-counter antihistamines, producing heavy sedation, impairing coordination, and carrying cardiac risks that need medical screening before use. It is considered the most sedating antihistamine in its class, and its approved uses for anxiety and pre-surgical sedation go well beyond what OTC allergy medications are designed to do.
How Hydroxyzine Differs From OTC Antihistamines
All antihistamines block histamine receptors to reduce allergic symptoms, but hydroxyzine does something extra. Because of its chemical structure, it is highly lipophilic, meaning it dissolves easily into fatty tissue. This lets it cross the blood-brain barrier with little resistance and bind to histamine receptors deep inside the central nervous system. That’s what produces its powerful calming and sedating effects.
Compare this to cetirizine (sold as Zyrtec), which is actually a direct metabolite of hydroxyzine. Your liver converts hydroxyzine into cetirizine after you take it. But cetirizine has a zwitterionic structure, a chemical property that makes it far less able to penetrate the brain. The result: cetirizine treats allergies with minimal drowsiness, while hydroxyzine causes substantial sedation and reduced alertness. That chemical difference is the core reason one is available over the counter and the other is not.
Even compared to diphenhydramine (Benadryl), which also causes drowsiness, hydroxyzine produces more sedation. In user-reported data, drowsiness occurs in about 22% of hydroxyzine users compared to roughly 16% of diphenhydramine users. Hydroxyzine also blocks muscarinic cholinergic receptors in the brain, adding anticholinergic side effects like dry mouth, constipation, confusion, and blurred vision on top of the sedation.
It Treats Anxiety, Not Just Allergies
Hydroxyzine is FDA-approved to treat generalized anxiety disorder (GAD), which puts it in a different regulatory category than a simple allergy pill. In a double-blind clinical trial of 334 outpatients diagnosed with GAD, hydroxyzine demonstrated both efficacy and safety for anxiety treatment over three months and was considered a viable alternative to benzodiazepines.
Prescribing a medication for anxiety requires a proper diagnosis. Anxiety disorders overlap with many other conditions, and sedating medications can mask symptoms of depression, substance use disorders, or neurological problems. A clinician needs to evaluate whether hydroxyzine is the right fit, whether other treatments have been tried, and whether the patient has risk factors that make the drug dangerous. None of that screening happens at a pharmacy counter.
Cardiac Risks That Require Screening
One of the more serious reasons hydroxyzine stays behind the prescription counter is its effect on heart rhythm. The drug can prolong the QT interval, a measure of how long the heart takes to recharge between beats. When that interval stretches too long, it raises the risk of a potentially fatal arrhythmia called torsade de pointes.
A review of safety data spanning from 1955 to 2016 identified 59 reports of QT prolongation or torsade de pointes linked to hydroxyzine. Over a more recent period with reliable sales tracking, the reporting rate was about 3.8 cases per million patient-years of use. That’s low in absolute terms, but every single case involving standard doses (100 mg or less) occurred in a patient who had at least one additional risk factor: pre-existing heart disease, electrolyte imbalances, or use of another medication known to affect heart rhythm. Nearly half of cases involved both cardiovascular disease and another QT-prolonging drug taken at the same time.
This is exactly the kind of risk a prescriber needs to evaluate before writing the prescription. Patients with heart failure, slow heart rates, a family history of long QT syndrome, or those taking certain other medications should either avoid hydroxyzine entirely or be monitored closely. That risk assessment simply cannot happen in an OTC setting.
Dangerous Interactions With Other Substances
Hydroxyzine amplifies the effects of other central nervous system depressants in ways that can become dangerous. When combined with alcohol, it increases dizziness, drowsiness, confusion, and impaired motor coordination beyond what either substance causes alone. The same applies to opioid painkillers. Research has found that hydroxyzine causes respiratory depression that adds to the respiratory depression from opioids, and this combined effect cannot be reversed with naloxone, the standard opioid overdose rescue drug.
Its anticholinergic properties also create concerns for people with asthma or chronic obstructive pulmonary disease. Anticholinergic drugs can thicken mucus in the airways and reduce the volume of bronchial secretions, potentially worsening breathing difficulties. A prescriber can weigh these risks against the benefits, adjust the dose, or choose a different medication entirely.
Particular Risks for Older Adults
The American Geriatrics Society’s Beers Criteria, a widely used guide for identifying medications that are potentially inappropriate for people over 65, specifically lists hydroxyzine as a drug to avoid. The recommendation is rated “strong” based on high-quality evidence. Older adults clear the drug from their bodies more slowly, increasing the intensity and duration of its anticholinergic effects. This raises the risk of confusion, falls, dry mouth, constipation, urinary retention, and cognitive decline.
When hydroxyzine is used as a sleep aid in older adults, tolerance develops over time, meaning it stops working for sleep while still causing side effects. A prescriber who knows a patient’s age, kidney function, and full medication list can steer them toward safer alternatives. Making hydroxyzine available without a prescription would remove that safety check for a population that is especially vulnerable to its harms.
Misuse and Potentiation Concerns
Although hydroxyzine is not a controlled substance and does not produce the kind of euphoria associated with benzodiazepines or opioids, it has a history of being used alongside those drugs to intensify their effects. In clinical settings, it was long added to opioid regimens with the belief that it would boost pain relief. Research has not confirmed that benefit, but the combination does reliably increase respiratory depression. This potentiation risk is another reason regulators keep it behind a prescription: a clinician can review what other medications a patient takes and flag combinations that could suppress breathing.
The sedation itself can also be misused. Because hydroxyzine is the most sedating antihistamine available, it can cause significant impairment in thinking, judgment, and coordination. Driving and operating machinery become genuinely dangerous, particularly during the first days of use or after dose increases. A prescriber sets expectations about these effects and adjusts the dose to balance benefit against impairment in a way that self-directed use would not.